IYW iShares U.S. Technology ETF

Expense Ratio
0.37%
Dividend
0.09%
Previous close
$272.59
Est. 12 months change
+16.65%
Projected Price
$317.98

Profitability Metrics

Return on Equity (ROE)
100.31%
Return on Assets (ROA)
21.76%
Return on Invested Capital (ROIC)
57.29%
Weighted Average Cost of Capital (WACC)
12.47%
ROIC - WACC
44.83%
Updated : 2026-10-06 19:46 ET

Valuation Metrics

P/E Ratio
32.94
Forward P/E
23.58
PEG Ratio
1.65
Debt Current Ratio
2.50

Growth & Cash Flow

Gross Margin
63.41%
Operating Margin
17.33%
FCF Margin
28.52%
TTM Revenue Growth
57.54%
Projected 12M EPS Growth
39.70%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NVDA17.17%
AAPL15.19%
MSFT12.11%
META3.37%
AMD3.27%
AVGO3.10%
MU3.00%
INTC2.56%
GOOGL2.42%
LRCX2.04%

ETF Analysis

Fund Overview

iShares U.S. Technology ETF (IYW) currently reports 148 stock positions (subject to change), placing it in the widely spread range by holdings breadth. The top line-up is NVDA (17.17%), AAPL (15.19%), MSFT (12.11%), with NVDA as the largest single weight at 17.17%. Together, the top three holdings account for 44.47%, which implies that short-term performance can be meaningfully influenced by a narrow set of large constituents. The weight distribution suggests a portfolio designed to capture thematic upside while avoiding excessive dependence on any single name outside the largest positions.

Profitability & Capital Efficiency

Assessing the quality of returns on invested capital, ROIC is 57.29%, WACC is 12.47%, and the economic spread is 44.83%. On balance, the underlying businesses generate returns on capital that dramatically exceed their funding costs — a rare and powerful compounding dynamic. Supporting metrics show ROE at 100.31% and ROA at 21.76%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

The current pricing of the underlying holdings reads trailing P/E of 32.94, forward P/E of 23.58, PEG of 1.65. The trailing-to-forward compression is moderate — supportive of valuation, but not a dramatic signal of earnings acceleration. The PEG ratio signals a portfolio priced at reasonable growth-adjusted value — adequate for the earnings outlook, without offering an obvious margin of safety. The current ratio of 2.50 is in an acceptable range, reflecting reasonable short-term financial health. In aggregate, the valuation reads as fair to moderately stretched — leaving the investment case dependent on earnings execution rather than multiple expansion.

Margins & Cash Generation

Looking at margins from gross to free cash flow, gross margin sits at 63.41%, operating margin at 17.33%, and free cash flow margin at 28.52%. The gross margin here is a standout, pointing to businesses with durable unit economics and limited commodity exposure. At this level, operating margins reflect businesses that are scaling with discipline without dramatic cost pressure. Outstanding free cash flow margins signal businesses that convert revenues into cash at rates that support both reinvestment and shareholder returns. Together, these margins describe a portfolio where business quality varies — and where macro or sector headwinds could disproportionately impact the weaker-margin holdings.

Growth & Forward Outlook

Projected 12-month EPS growth of 39.7% adds a powerful forward signal — analyst consensus expects earnings to accelerate materially, which, if delivered, could make current multiples look increasingly modest. Zooming out from the valuation discussion, TTM revenue growth of 57.54% pointing to sustained and broad-based revenue growth within the basket, while the estimated 12-month price change of 16.82%, where target prices point to mid-range appreciation potential from current levels. Anchoring to reported revenues provides discipline; analyst price targets add context about how the market currently values that operating reality. The path to realizing analyst-implied returns runs through revenue execution, margin stability, and a macro environment that doesn't undermine either. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The quantitative profile, taken as a whole, is above average on virtually every dimension that matters for long-term return generation.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.